Ankylosing spondylitis treatment market is projected to grow at a considerable CAGR of around 5% during the forecast period (2020-2026). The growing incidence and prevalence of ankylosing spondylitis due to a sedentary lifestyle along with the introduction of novel products are expected to drive market growth over the forecast period. The increasing per capita income, improving healthcare infrastructure, and growing investment in R&D of novel therapies are the other factors that are contributing towards the growth of the global market. The HealthWell Foundation, an independent non-profit organization had launched a new program to assist patients who have been diagnosed with ankylosing spondylitis.